On the kinetic features of orexin receptor antagonists at orexin receptors, transduction systems and receptor binding

• Κύριοι συγγραφείς: Daniel Hoyer (Συγγραφέας), Laura H. Jacobson (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Elsevier, 2024-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Orexin receptor antagonists are on the market or under development for the treatment of insomnia and a number of other neuropsychiatric disorders. Currently, suvorexant, lemborexant and daridorexant, three dual orexin receptor antagonists (DORAs) have received market approval by regulatory authoriti...